Wintrust Investments’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$176K Buy
2,384
+177
+8% +$13.1K 0.15% 110
2024
Q3
$145K Sell
2,207
-1,212
-35% -$79.6K 0.11% 164
2024
Q2
$316K Buy
3,419
+170
+5% +$15.7K 0.03% 367
2024
Q1
$310K Sell
3,249
-14,730
-82% -$1.41M 0.03% 365
2023
Q4
$1.37M Buy
17,979
+2,487
+16% +$190K 0.13% 151
2023
Q3
$1.07M Buy
15,492
+3,722
+32% +$258K 0.11% 161
2023
Q2
$1.11M Buy
11,770
+735
+7% +$69.3K 0.11% 159
2023
Q1
$913K Buy
11,035
+2,700
+32% +$223K 0.12% 141
2022
Q4
$622K Buy
+8,335
New +$622K 0.08% 186
2022
Q2
Sell
-5,215
Closed -$614K 389
2022
Q1
$614K Sell
5,215
-950
-15% -$112K 0.06% 226
2021
Q4
$799K Sell
6,165
-2,540
-29% -$329K 0.08% 199
2021
Q3
$942K Sell
8,705
-195
-2% -$21.1K 0.13% 125
2021
Q2
$900K Buy
8,900
+765
+9% +$77.4K 0.09% 173
2021
Q1
$686K Buy
+8,135
New +$686K 0.07% 218
2020
Q4
Sell
-4,284
Closed -$342K 236
2020
Q3
$342K Buy
4,284
+329
+8% +$26.3K 0.05% 249
2020
Q2
$273K Sell
3,955
-245
-6% -$16.9K 0.04% 279
2020
Q1
$264K Buy
4,200
+1,170
+39% +$73.5K 0.04% 257
2019
Q4
$236K Sell
3,030
-1,950
-39% -$152K 0.03% 323
2019
Q3
$365K Buy
4,980
+888
+22% +$65.1K 0.05% 254
2019
Q2
$252K Hold
4,092
0.04% 316
2019
Q1
$261K Sell
4,092
-150
-4% -$9.57K 0.04% 291
2018
Q4
$217K Sell
4,242
-738
-15% -$37.8K 0.04% 300
2018
Q3
$289K Sell
4,980
-45
-0.9% -$2.61K 0.05% 290
2018
Q2
$244K Sell
5,025
-1,740
-26% -$84.5K 0.04% 308
2018
Q1
$315K Hold
6,765
0.08% 192
2017
Q4
$254K Hold
6,765
0.06% 248
2017
Q3
$246K Sell
6,765
-225
-3% -$8.18K 0.06% 242
2017
Q2
$275K Sell
6,990
-300
-4% -$11.8K 0.07% 241
2017
Q1
$229K Buy
+7,290
New +$229K 0.07% 262
2016
Q4
Sell
-5,490
Closed -$221K 215
2016
Q3
$221K Buy
+5,490
New +$221K 0.1% 175